Literature DB >> 12376524

No association between a stop codon polymorphism in RAD52 and breast cancer risk.

Jiali Han1, Susan E Hankinson, Immaculata De Vivo, Graham A Colditz, David J Hunter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12376524

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  3 in total

1.  RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  A K Siraj; M Al-Rasheed; M Ibrahim; K Siddiqui; F Al-Dayel; O Al-Sanea; S Uddin; K Al-Kuraya
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

2.  Hereditary breast cancer: ever more pieces to the polygenic puzzle.

Authors:  Natalia Bogdanova; Sonja Helbig; Thilo Dörk
Journal:  Hered Cancer Clin Pract       Date:  2013-09-11       Impact factor: 2.857

3.  Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.

Authors:  Jaime L Stafford; Gregory Dyson; Nancy K Levin; Sophia Chaudhry; Rita Rosati; Hasini Kalpage; Courtney Wernette; Nancie Petrucelli; Michael S Simon; Michael A Tainsky
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.